[Source: Genome Web News] – A start-up company led by a former Critical Path Institute official has received $1.5 million in private equity funding, according to a filing with the Securities and Exchange Commission.
The company, United States Diagnostics Standards, or USDS Inc., was founded by Jeffrey Cossman, who served as chief scientific officer of C-Path and directed the public-private consortium’s Washington, DC-area office.
USDS was launched as an independent certification body for laboratory and pathology diagnostics and aims to help diagnostic developers verify the analytical and clinical performance of their tests before they are submitted to the FDA for approval.
For more information: Independent Dx Certification Startup USDS Raises $1.5M